Healthcare >> CEO Interviews >> May 13, 2003
DR. KEVIN E. NOONAN, a Partner with McDonnell Boehnen Hulbert &
Bergoff has extensive experience in biotechnology and the
chemical arts. A registered patent agent since 1991, Dr. Noonan
brings over 10 years' experience as a molecular biologist working
on high-technology problems to his legal work. Dr. Noonan has
wide experience in all aspects of patent prosecution and client
counseling on validity, infringement and patenting strategy
matters. He represents pharmaceutical and biotechnology companies
both large and small, and he is particularly experienced in
representing university clients in both patent prosecution and
licensing to outside investors. Dr. Noonan received a PhD in
Molecular Biology from Princeton University, where his thesis
work involved genetic analysis of oncogenesis in mammalian cells.
Dr. Noonan was also a postdoctoral fellow supported by the
National Cancer Institute at the University of Illinois at
Chicago, where he studied multidrug resistance in mammalian tumor
cells. During his fellowship Dr. Noonan developed a variety of
novel methods based on the polymerase chain reaction, including
quantitative analysis of mammalian gene expression. Dr. Noonan is
the author of several articles and has lectured extensively on
his scientific work. Dr. Noonan graduated cum laude from the John
Marshall Law School. He is admitted to practice in Illinois and
Massachusetts and is currently an Adjunct Professor of Law at the
De Paul University Law School, where he teaches biotechnology
patent law. Profile
McDonnell Boehnen Hulbert & Berghoff?
Dr. Noonan: McDonnel Boehnan Hulbert & Berghoff is a patent law
firm that was started
